Euro-Med Laboratories Philippines (PHS:EURO) Other Current Assets: ₱455 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PHS:EURO Euro-Med Laboratories Philippines Inc PHS:EURO
82 GF Score
Price ₱1.10
GF Value ₱1.03
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Euro-Med Laboratories Philippines Other Current Assets?

Euro-Med Laboratories Philippines PHS:EURO 82 Other Current Assets is ₱455 Mil as of Mar. 2026. GuruFocus rates PHS:EURO with a GF Score™ of 82/100 and a GF Value™ of ₱1.03 (Fairly Valued). The stock has 7 warning signs investors should review.

Euro-Med Laboratories Philippines's other current assets for the quarter that ended in Mar. 2026 was ₱455 Mil.

Euro-Med Laboratories Philippines's quarterly other current assets increased from Sep. 2025 (₱525 Mil) to Dec. 2025 (₱559 Mil) but then declined from Dec. 2025 (₱559 Mil) to Mar. 2026 (₱455Mil).

Euro-Med Laboratories Philippines's annual other current assets declined from Dec. 2023 (₱647 Mil) to Dec. 2024 (₱536 Mil) increased from Dec. 2024 (₱536 Mil) to Dec. 2025 (₱559 Mil).


Euro-Med Laboratories Philippines Other Current Assets Related Terms


Euro-Med Laboratories Philippines Other Current Assets Historical Data

* Premium members only.

The historical data trend for Euro-Med Laboratories Philippines's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Euro-Med Laboratories Philippines Other Current Assets Chart

Euro-Med Laboratories Philippines Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 546.93 592.22 646.83 536.18 559.19

Euro-Med Laboratories Philippines Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 489.54 458.49 525.21 559.19 454.63
PHS:EURO
82GF Score
Euro-Med Laboratories Philippines Inc PHS:EURO
Other Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Euro-Med Laboratories Philippines Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.

Frequently Asked Questions Learn more about Other Current Assets →
What does a Other Current Assets of ₱455 Mil mean?
Euro-Med Laboratories Philippines (PHS:EURO) has a Other Current Assets of ₱455 Mil as of Mar. 2026. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Euro-Med Laboratories Philippines.
Is Euro-Med Laboratories Philippines' Other Current Assets too high?
Euro-Med Laboratories Philippines' current Other Current Assets is ₱455 Mil. Overall, Euro-Med Laboratories Philippines has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Euro-Med Laboratories Philippines' Other Current Assets compare to ZTS and UTHR?
Euro-Med Laboratories Philippines' Other Current Assets of ₱455 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Assets for a Drug Manufacturers company?
A good Other Current Assets depends on the Drug Manufacturers industry context. However, Other Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Assets mean?
A high Other Current Assets can signal that a stock is expensive relative to its fundamentals. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Euro-Med Laboratories Philippines. Euro-Med Laboratories Philippines's current Other Current Assets is ₱455 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euro-Med Laboratories Philippines stock overvalued right now?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines (PHS:EURO) is currently considered Fairly Valued. The stock's GF Value™ is ₱1.03, compared to a current price of ₱1.10 — trading 6.8% above its estimated fair value. The current Other Current Assets is ₱455 Mil. Euro-Med Laboratories Philippines' overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Assets calculated?
Other Current Assets is calculated from a company's financial statements. For Euro-Med Laboratories Philippines (PHS:EURO), the current Other Current Assets is ₱455 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Euro-Med Laboratories Philippines (PHS:EURO) Overvalued in 2026?

Based on GuruFocus' analysis, Euro-Med Laboratories Philippines stock appears to be overvalued. The current stock price of ₱1.10 is trading 6.8% above its estimated GF Value™ of ₱1.03. GuruFocus considers Euro-Med Laboratories Philippines to be Fairly Valued.

Key valuation signals for PHS:EURO:

  • Other Current Assets: ₱455 Mil
  • GF Value™: ₱1.03 vs. price of ₱1.10 (6.8% above fair value)
  • GF Score™: 82/100 with 7 warning signs

No single metric tells the full story. See the PHS:EURO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Euro-Med Laboratories Philippines Business Description

Address San Marcelino Street, United Nations Avenue corner, PPL Building, 2nd floor, Manila, PHL, 1000
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small-volume parenterals and other solutions. The company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation, and dialysis. The Company also manufactures intravenous fluids in glass bottles, hemodialysis concentrates, ophthalmic products and disinfectants.
82GF Score

Get the complete analysis for PHS:EURO

Other Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₱1.10
Price
₱1.03
GF Value